Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
ended up with shingles; This non-serious case was reported by a consumer and described the occurrence of shingles in a 78-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 28-JUL-2025, the patient received the 2nd dose of Shingles vaccine. On 29-JUL-2025, 1 days after receiving Shingles vaccine, the patient experienced shingles (Verbatim: ended up with shingles). The patient was treated with valaciclovir (Valacyclovir). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 10-AUG-2025 The patient received shingles vaccine on 28-Jul-2025 and ended up with shingles from 29-Jul-2025. Reporter seriousness for ended up with shingles was reported as intervention required.